Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wolff

Showing results (21-30 of 207) with videos related to

Pageof 21
Sort By:
Bone Marrow Transplantation|July 4, 2021
Steroid-refractory chronic graft-versus-host disease: treatment options and patient managementDaniel Wolff, Giancarlo Fatobene, Vanderson Rocha, et al.
Oncology Research and Treatment|July 7, 2017
Potential Role of the PD-1/PD-L1 Axis in the Immune Regulation of Chronic GVHDSebastian Klobuch, Daniela Weber, Barbara Holler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Sirolimus in combination with tacrolimus in allogeneic stem cell transplantation--timing and conditioning regimen may be crucialDaniel Wolff, Holger Andree, Inken Hilgendorf, et al.
Deutsches Arzteblatt International|November 25, 2011
The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and SwitzerlandDaniel Wolff, Hartmut Bertz, Hildegard Greinix, et al.
Transfusion|July 27, 2016
Technical comparison of four different extracorporeal photopheresis systemsAndreas Brosig, Viola Hähnel, Evelyn Orsó, et al.
Immunopharmacology and Immunotoxicology|March 5, 2014
Cytostatic conditioning in experimental allogeneic bone marrow transplantation: Busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitutionAbdellatif Bouazzaoui, Sabine Dickhöfer, Marina Kreuz, et al.
Radiation Oncology (London, England)|November 29, 2022
Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiationIsabella Gruber, Oliver Koelbl, Wolfgang Herr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 26, 2016
Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational StudyMatthias Grube, Ernst Holler, Daniela Weber, et al.
Clinical Transplantation|September 13, 2016
ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantationMatthias Grube, Daniel Wolff, Norbert Ahrens, et al.
Deutsches Arzteblatt International|March 24, 2015
Long-term follow-up after allogeneic stem cell transplantationInken Hilgendorf, Hildegard Greinix, Jörg P Halter, et al.
Pageof 21

Showing results (21-30 of 207) with videos related to

Sort By:
Pageof 21
Bone Marrow Transplantation|July 4, 2021
Steroid-refractory chronic graft-versus-host disease: treatment options and patient managementDaniel Wolff, Giancarlo Fatobene, Vanderson Rocha, et al.
Oncology Research and Treatment|July 7, 2017
Potential Role of the PD-1/PD-L1 Axis in the Immune Regulation of Chronic GVHDSebastian Klobuch, Daniela Weber, Barbara Holler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Sirolimus in combination with tacrolimus in allogeneic stem cell transplantation--timing and conditioning regimen may be crucialDaniel Wolff, Holger Andree, Inken Hilgendorf, et al.
Deutsches Arzteblatt International|November 25, 2011
The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and SwitzerlandDaniel Wolff, Hartmut Bertz, Hildegard Greinix, et al.
Transfusion|July 27, 2016
Technical comparison of four different extracorporeal photopheresis systemsAndreas Brosig, Viola Hähnel, Evelyn Orsó, et al.
Immunopharmacology and Immunotoxicology|March 5, 2014
Cytostatic conditioning in experimental allogeneic bone marrow transplantation: Busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitutionAbdellatif Bouazzaoui, Sabine Dickhöfer, Marina Kreuz, et al.
Radiation Oncology (London, England)|November 29, 2022
Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiationIsabella Gruber, Oliver Koelbl, Wolfgang Herr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 26, 2016
Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational StudyMatthias Grube, Ernst Holler, Daniela Weber, et al.
Clinical Transplantation|September 13, 2016
ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantationMatthias Grube, Daniel Wolff, Norbert Ahrens, et al.
Deutsches Arzteblatt International|March 24, 2015
Long-term follow-up after allogeneic stem cell transplantationInken Hilgendorf, Hildegard Greinix, Jörg P Halter, et al.
Pageof 21